Animal models as tools to study the pathophysiology of depression.

The incidence of depressive illness is high worldwide, and the inadequacy of currently available drug treatments contributes to the significant health burden associated with depression. A basic understanding of the underlying disease processes in depression is lacking; therefore, recreating the disease in animal models is not possible. Popular current models of depression creatively merge ethologically valid behavioral assays with the latest technological advances in molecular biology. Within this context, this study aims to evaluate animal models of depression and determine which has the best face, construct, and predictive validity. These models differ in the degree to which they produce features that resemble a depressive-like state, and models that include stress exposure are widely used. Paradigms that employ acute or sub-chronic stress exposure include learned helplessness, the forced swimming test, the tail suspension test, maternal deprivation, chronic mild stress, and sleep deprivation, to name but a few, all of which employ relatively short-term exposure to inescapable or uncontrollable stress and can reliably detect antidepressant drug response.

[1]  M. Seligman,et al.  Learned helplessness in the rat. , 1975, Journal of comparative and physiological psychology.

[2]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.

[3]  B. Carroll,et al.  Acute and chronic stress effects on open field activity in the rat: Implications for a model of depression , 1981, Neuroscience & Biobehavioral Reviews.

[4]  J. Pujol,et al.  Variation of tryptophan-5-hydroxylase concentration in the rat raphe dorsalis nucleus afterp-chlorophenylalanine administration. II. Anatomical distribution of the tryptophan-5-hydroxylase protein and regional variation of its turnover rate , 1990, Brain Research.

[5]  D. Kohn Long-term treatment , 1993 .

[6]  P. Willner Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation , 1997, Psychopharmacology.

[7]  D. Murphy,et al.  Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. , 1998, Molecular pharmacology.

[8]  H. Anisman,et al.  Do early-life events permanently alter behavioral and hormonal responses to stressors? , 1998, International Journal of Developmental Neuroscience.

[9]  C. Nemeroff,et al.  The serotonin transporter and depression , 1998, Depression and anxiety.

[10]  M. Parmentier,et al.  Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. , 1999, Science.

[11]  K. Lesch,et al.  Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter , 1999, Neuroscience Letters.

[12]  K. Lesch,et al.  Altered expression and functions of serotonin 5‐HT1A and 5‐HT1B receptors in knock‐out mice lacking the 5‐HT transporter , 2000, The European journal of neuroscience.

[13]  Christian Rosenmund,et al.  Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons , 2000, Nature.

[14]  M. Molina-hernandez,et al.  Long photoperiod regimen may produce antidepressant actions in the male rat , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[15]  Kei Yamamoto,et al.  Differential effect of short-term REM sleep deprivation on NGF and BDNF protein levels in the rat brain , 2000, Brain Research.

[16]  R. Porsolt,et al.  Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice , 2007, Current protocols in pharmacology.

[17]  K. Lesch,et al.  Functional Consequences of 5-HT Transporter Gene Disruption on 5-HT1A Receptor-Mediated Regulation of Dorsal Raphe and Hippocampal Cell Activity , 2001, The Journal of Neuroscience.

[18]  S. Okuyama,et al.  Availability of Learned Helplessness Test as a Model of Depression Compared to a Forced Swimming Test in Rats , 2001, Pharmacology.

[19]  M. Parmentier,et al.  Involvement of CB1 cannabinoid receptors in emotional behaviour , 2002, Psychopharmacology.

[20]  C. Nemeroff,et al.  The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies , 2001, Biological Psychiatry.

[21]  G F Mason,et al.  Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments , 2002, Molecular Psychiatry.

[22]  P. Gass,et al.  Reduced cell proliferation in the dentate gyrusis not correlated with the development of learned helplessness , 2003, Biological Psychiatry.

[23]  D. Murphy,et al.  Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression , 2003, Biological Psychiatry.

[24]  M. Bader,et al.  A unique central tryptophan hydroxylase isoform. , 2003, Biochemical pharmacology.

[25]  Ronald S Duman,et al.  Cell Proliferation in Adult Hippocampus is Decreased by Inescapable Stress: Reversal by Fluoxetine Treatment , 2003, Neuropsychopharmacology.

[26]  S. Hisano Vesicular glutamate transporters in the brain , 2003, Anatomical science international.

[27]  Klaus-Peter Lesch,et al.  Mice Lacking the Serotonin Transporter Exhibit 5-HT1A Receptor-Mediated Abnormalities in Tests for Anxiety-like Behavior , 2003, Neuropsychopharmacology.

[28]  R. Spanagel,et al.  Reduced sensitivity to reward in CB1 knockout mice , 2004, Psychopharmacology.

[29]  D. Copenhagen,et al.  Vesicular Glutamate Transporters 1 and 2 Target to Functionally Distinct Synaptic Release Sites , 2004, Science.

[30]  J. Nobrega,et al.  Increased homocysteine levels associated with sex and stress in the learned helplessness model of depression , 2004, Pharmacology Biochemistry and Behavior.

[31]  H. Möller,et al.  SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression , 2004, Molecular Psychiatry.

[32]  B. Thierry,et al.  The tail suspension test: Ethical considerations , 2004, Psychopharmacology.

[33]  John H Krystal,et al.  Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. , 2004, Archives of general psychiatry.

[34]  Christian Rosenmund,et al.  An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Blacklock,et al.  Estrogen selectively increases sensory nociceptor innervation of arterioles in the female rat , 2004, Brain Research.

[36]  T. Sotnikova,et al.  Tryptophan Hydroxylase-2 Controls Brain Serotonin Synthesis , 2004, Science.

[37]  B. Gorzalka,et al.  Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression? , 2005, Behavioural pharmacology.

[38]  J. Cryan,et al.  The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice , 2005, Neuroscience & Biobehavioral Reviews.

[39]  P. Gass,et al.  Mutant mouse models of depression: Candidate genes and current mouse lines , 2005, Neuroscience & Biobehavioral Reviews.

[40]  Nathan R. Wilson,et al.  Presynaptic Regulation of Quantal Size by the Vesicular Glutamate Transporter VGLUT1 , 2005, The Journal of Neuroscience.

[41]  B. Leonard,et al.  The olfactory bulbectomised rat as a model of depression , 2005, Neuroscience & Biobehavioral Reviews.

[42]  J. Feldon,et al.  Early deprivation leads to altered behavioural, autonomic and endocrine responses to environmental challenge in adult Fischer rats , 2006, The European journal of neuroscience.

[43]  J. Neumaier,et al.  Estrogen Selectively Increases Tryptophan Hydroxylase-2 mRNA Expression in Distinct Subregions of Rat Midbrain Raphe Nucleus: Association between Gene Expression and Anxiety Behavior in the Open Field , 2006, Biological Psychiatry.

[44]  B. McEwen Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load. , 2006, Metabolism: clinical and experimental.

[45]  K. Lesch,et al.  Inactivation of 5HT transport in mice: modeling altered 5HT homeostasis implicated in emotional dysfunction, affective disorders, and somatic syndromes. , 2006, Handbook of experimental pharmacology.

[46]  K. Sleegers,et al.  Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population. , 2006, Archives of General Psychiatry.

[47]  O. Valverde,et al.  Involvement of the endocannabinoid system in drug addiction , 2006, Trends in Neurosciences.

[48]  O. Valverde,et al.  CB1 knockout mice display impaired functionality of 5‐HT1A and 5‐HT2A/C receptors , 2007, Journal of neurochemistry.

[49]  P. Matthews,et al.  Reduction in Occipital Cortex γ-Aminobutyric Acid Concentrations in Medication-Free Recovered Unipolar Depressed and Bipolar Subjects , 2007, Biological Psychiatry.

[50]  K. Lesch,et al.  Long story short: the serotonin transporter in emotion regulation and social cognition , 2007, Nature Neuroscience.

[51]  S. Totterdell,et al.  Enhanced anxiety, depressive‐like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1) , 2007, The European journal of neuroscience.

[52]  M. Irwin,et al.  Depressive disorders and immunity: 20 years of progress and discovery , 2007, Brain, Behavior, and Immunity.

[53]  R. Hellweg,et al.  Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas , 2007, Neurobiology of Disease.

[54]  M. Austin,et al.  3,4-Methylenedioxymethamphetamine induces differential regulation of tryptophan hydroxylase 2 protein and mRNA levels in the rat dorsal raphe nucleus , 2008, Neuroscience.

[55]  D. Schulz,et al.  Behavioral despair is differentially affected by the length and timing of photic stimulation in the dark phase of an L/D cycle , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[56]  V. Arango,et al.  Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides , 2008, Molecular Psychiatry.

[57]  G. Rosoklija,et al.  Genetic architecture of the human tryptophan hydroxylase 2 Gene: existence of neural isoforms and relevance for major depression , 2008, Molecular Psychiatry.

[58]  K. Lesch,et al.  Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice , 2008, Journal of Neural Transmission.

[59]  Eric J. Nestler,et al.  The molecular neurobiology of depression , 2008, Nature.

[60]  C. Ledent,et al.  BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice , 2008, Journal of neurochemistry.

[61]  A. Deutch,et al.  Glucocorticoid modulation of tryptophan hydroxylase-2 protein in raphe nuclei and 5-hydroxytryptophan concentrations in frontal cortex of C57/Bl6 mice , 2008, Molecular Psychiatry.

[62]  Dennis L. Murphy,et al.  Targeting the murine serotonin transporter: insights into human neurobiology , 2008, Nature Reviews Neuroscience.

[63]  K. Lesch,et al.  Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice. , 2008, The international journal of neuropsychopharmacology.

[64]  C. Belzung,et al.  Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress , 2009, Behavioural Brain Research.

[65]  M. Regulska,et al.  The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats , 2009, Psychoneuroendocrinology.

[66]  G. Réus,et al.  Effects of chronic mild stress on the oxidative parameters in the rat brain , 2009, Neurochemistry International.

[67]  S. Tufik,et al.  Increased susceptibility to development of anhedonia in rats with chronic peripheral nerve injury: Involvement of sleep deprivation? , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[68]  Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia , 2009 .

[69]  J. Harro,et al.  Increased Vulnerability to Depressive-Like Behavior of Mice with Decreased Expression of VGLUT1 , 2009, Biological Psychiatry.

[70]  L. Lanfumey,et al.  Lack of CB1 receptor activity impairs serotonergic negative feedback , 2009, Journal of neurochemistry.

[71]  P. Buckley,et al.  Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer , 2009 .

[72]  K. Lesch,et al.  Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: Convergent data from Tph2 knockout mice , 2009, European Neuropsychopharmacology.

[73]  Sun-Hye Choi,et al.  Effects of reboxetine and citalopram pretreatment on changes in cocaine and amphetamine regulated transcript (CART) expression in rat brain induced by the forced swimming test. , 2010, European journal of pharmacology.

[74]  S. Hyman,et al.  Animal models of neuropsychiatric disorders , 2010, Nature Neuroscience.

[75]  J. Hannestad,et al.  A critical review of human endotoxin administration as an experimental paradigm of depression , 2010, Neuroscience & Biobehavioral Reviews.

[76]  G. Réus,et al.  Maternal Deprivation Induces Depressive-like Behaviour and Alters Neurotrophin Levels in the Rat Brain , 2011, Neurochemical Research.

[77]  Petr Tvrdik,et al.  Hematopoietic Origin of Pathological Grooming in Hoxb8 Mutant Mice , 2010, Cell.

[78]  R. D'Hooge,et al.  Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning. , 2010, Cerebral cortex.

[79]  G. Réus,et al.  Effects of β-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: Further evidence of antidepressant properties , 2010, Brain Research Bulletin.

[80]  C. Che,et al.  Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain , 2010, Behavioural Brain Research.

[81]  A. Bilkei-Gorzo,et al.  Exposure of mice to long-light: A new animal model to study depression , 2010, European Neuropsychopharmacology.

[82]  S. Sarasso,et al.  Electrophysiological traces of visuomotor learning and their renormalization after sleep , 2011, Clinical Neurophysiology.

[83]  Wild Type Mice , 2011 .

[84]  R. Porsolt,et al.  Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice , 2011, Current protocols in neuroscience.

[85]  N. Kronfeld-Schor,et al.  Antidepressants Reverse Short-Photoperiod-Induced, Forced Swim Test Depression-Like Behavior in the Diurnal Fat Sand Rat: Further Support for the Utilization of Diurnal Rodents for Modeling Affective Disorders , 2011, Neuropsychobiology.

[86]  Wenzheng Zhang,et al.  Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: Involvement in depression , 2011, Behavioural Brain Research.

[87]  G. Tononi,et al.  Overnight changes in waking auditory evoked potential amplitude reflect altered sleep homeostasis in major depression , 2012, Acta psychiatrica Scandinavica.

[88]  S. Kakkos,et al.  Patients With Cancer , 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[89]  D. Hines,et al.  Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling , 2013, Translational Psychiatry.